KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Operating Leases: 2022-2024

Historic Operating Leases for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Dec 2024 value amounting to $438.8 million.

  • Ginkgo Bioworks Holdings' Operating Leases fell 5.10% to $422.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $422.9 million, marking a year-over-year decrease of 5.10%. This contributed to the annual value of $438.8 million for FY2024, which is 97.79% up from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' Operating Leases stood at $438.8 million, which was up 97.79% from $221.8 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Operating Leases ranged from a high of $438.8 million in FY2024 and a low of $221.8 million during FY2023.
  • Its 3-year average for Operating Leases is $358.0 million, with a median of $413.3 million in 2022.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Operating Leases crashed by 46.32% in 2023 and then skyrocketed by 97.79% in 2024.
  • Ginkgo Bioworks Holdings' Operating Leases (Yearly) stood at $413.3 million in 2022, then plummeted by 46.32% to $221.8 million in 2023, then spiked by 97.79% to $438.8 million in 2024.